You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sorafenib

Showing 951 - 975 of 1,094
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Tampa, Philadelphia (Sorafenib (Nexavar, BAY43-9006))

Completed
  • Neoplasms
  • Sorafenib (Nexavar, BAY43-9006)
  • Tampa, Florida
  • +1 more
May 22, 2013

Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Cancer Trial in Durham (drug, biological,

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • sorafenib tosylate
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Jul 1, 2013

Metastatic Colorectal Cancer Trial in Ottawa (sorafenib + FOLFIRI)

Completed
  • Metastatic Colorectal Cancer
  • sorafenib + FOLFIRI
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
May 9, 2013

Medullary Thyroid Carcinoma Trial in Ulm (Sorafenib)

Withdrawn
  • Medullary Thyroid Carcinoma
  • Sorafenib
  • Ulm, Baden-Wuerttemberg, Germany
    University Hospital Ulm, Clinic for Nuclear Medicine
May 16, 2013

Hepatocellular Carcinoma Trial (HR, FOLFOX4)

Unknown status
  • Hepatocellular Carcinoma
  • (no location specified)
May 20, 2015

Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma Trial in Chicago, Boston (sorafenib

Completed
  • Epithelial Mesothelioma
  • +7 more
  • sorafenib tosylate
  • laboratory biomarker analysis
  • Chicago, Illinois
  • +1 more
Jun 4, 2013

Hand-foot Skin Reaction, Rash Trial in Chicago (urea 40% cream, fluocinonide 0.05% cream, tazarotene 0.1% cream)

Terminated
Has Results
  • Hand-foot Skin Reaction
  • Rash
  • urea 40% cream
  • +3 more
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine, Department
May 28, 2013

Hepatocellular Carcinoma Trial in Guangzhou (RFA, Oxaliplatin, 5-Fluorouracil/Leucovorin)

Unknown status
  • Hepatocellular Carcinoma
  • RFA
  • +2 more
  • Guangzhou, Guangdong, China
    Zhen-Wei Peng
Apr 21, 2015

Hepatocellular Carcinoma, Portal Vein Tumor Thrombosis Trial in Seoul (Scheduled interval TACE - RT)

Unknown status
  • Hepatocellular Carcinoma
  • Portal Vein Tumor Thrombosis
  • Scheduled interval TACE - RT
  • Seoul, Korea, Republic of
    Samsung Medical Center
Dec 3, 2014

Symptom Burden Associated With Advanced Renal Cell Carcinoma in

Completed
  • Carcinoma, Renal Cell
  • Targeted agents indicated in management of advanced/metastatic RCC (sunitinib, sorafenib, bevacizumab, and pazopanib)
  • (no location specified)
May 9, 2013

Renal Cell Carcinoma Trial in Worldwide (Sorafenib, temsirolimus (Torisel))

Completed
Has Results
  • Renal Cell Carcinoma
  • Sorafenib
  • temsirolimus (Torisel)
  • Duarte, California
  • +127 more
Oct 28, 2013

Locally Metastatic Malignant Tumor Trial (Everolimus and sorafenib, Sunitinib monotherapy)

Withdrawn
  • Locally Metastatic Malignant Neoplasm
  • Everolimus and sorafenib
  • Sunitinib monotherapy
  • (no location specified)
Apr 4, 2013

Soft Tissue Sarcoma Trial in Sacramento (Sorafenib)

Completed
Has Results
  • Soft Tissue Sarcoma
  • Sorafenib
  • Sacramento, California
    University of california, Davis Medical Center
Apr 9, 2013

Kidney Cancer Trial in United Kingdom (sorafenib tosylate, adjuvant therapy)

Completed
  • Kidney Cancer
  • sorafenib tosylate
  • adjuvant therapy
  • Bournemouth, England, United Kingdom
  • +38 more
Aug 9, 2013

Clear Cell Renal Cell Carcinoma Trial in Auckland (Dovitinib)

Unknown status
  • Clear Cell Renal Cell Carcinoma
  • Auckland, New Zealand
    Auckland Hospital
Feb 1, 2015

Hepatocellular Carcinoma Trial (Radiation therapy, Transarterial chemoembolization)

Withdrawn
  • Hepatocellular Carcinoma
  • Radiation therapy
  • Transarterial chemoembolization
  • (no location specified)
Jun 24, 2014

Hepatocellular Carcinoma Trial in Worldwide (RAD001, RAD001, sorafenib)

Terminated
  • Hepatocellular Carcinoma
  • Duarte, California
  • +7 more
Apr 9, 2013

Sorafenib or Regorafenib on P63 Expression and Keratinocyte

Terminated
  • Renal Cell Carcinoma
  • +2 more
  • skin punch biopsy
  • Lebanon, New Hampshire
  • +1 more
Apr 11, 2013

Free Survival And Overall Survival In A National Cohort Of

Completed
  • Renal Cell Carcinoma
  • Non-interventional
  • Herlev, Denmark
    University of Copenhagen Herlev Hospital
Aug 15, 2014

Osteosarcoma Trial in Italy (sorafenib)

Completed
  • Osteosarcoma
  • sorafenib
  • Candiolo, Torino, Italy
  • +3 more
Mar 26, 2013

Metastatic Renal Cell Carcinoma Trial in Yamagata (Sorafenib-sunitinib, Sunitinib-sorafenib)

Unknown status
  • Metastatic Renal Cell Carcinoma
  • Yamagata, Japan
    Yamagata University Faculty of Medicine
Feb 21, 2013

Symptom Burden Associated With Advanced Renal Cell Carcinoma in

Completed
  • Carcinoma, Renal Cell
  • Targeted agents indicated in management of advanced/metastatic RCC (sunitinib, sorafenib, bevacizumab, and pazopanib)
  • (no location specified)
May 9, 2013

Breast Cancer Trial in United States (Doxorubicin, Cyclophosphamide, Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • Jacksonville, Florida
  • +7 more
Mar 25, 2013

Carcinoma, Hepatocellular Trial in Japan, Korea, Republic of (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Hepatocellular
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Nagoya, Aichi, Japan
  • +74 more
Nov 26, 2013

Multiple Myeloma Trial in Bethesda, Nashville (Bortezomib, Sorafenib)

Completed
Has Results
  • Multiple Myeloma
  • Bethesda, Maryland
  • +1 more
Jan 23, 2013